XtalPi logo

XtalPi Funding & Investors

XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.

http://www.xtalpi.com/

Total Amount Raised:

XtalPi Funding Rounds

  • Series D

    $400,000,000

    Series D Investors

    HOPU Investment
    OrbiMed Advisors
    Sino Biopharmaceutical
    5Y Capital
    Sequoia Capital China
    Taihill Venture
  • Series C

    $318,800,000

    Series C Investors

    5Y Capital
    PICC Asset Management Co.
    SoftBank Vision Fund
    SIG China (SIG Asia Investments)
    Tencent
    China Life Healthcare Fund
    Sequoia Capital China
    IMO Ventures
    CITIC Capital Holdings
    CMB International's Telecom Fund.
    Oceanpine Capital
    Shunwei Capital
    Mirae Asset
    Morningside Capital
  • Series B

    $46,000,000

    Series B Investors

    China Life Healthcare Fund
    Yael Capital
    SIG China (SIG Asia Investments)
    HT Capital
  • Series B

    $15,000,000

    Series B Investors

    Sequoia Capital China
    Alphabet
    Tencent
  • Series A

    60,751 CNY

    Series A Investors

    ZhenFund
  • Series A

    1,231,952 CNY

    Series A Investors

    Frees Fund
    ZhenFund
  • Series A

    $5,000,000

    Series A Investors

    Tencent
    Frees Fund
    ZhenFund
  • Angel

    $309,000

    Angel Investors

    Renren
Funding info provided by Diffbot.